CD8A and neoplasm: In TNBC, ATM inhibition increased MHC-I expression through a c-Jun/TNF-α/p-STAT1 axis, augmented CD8+ T-cell infiltration and cytotoxicity, slowed tumor growth, and sensitized tumors to PD-1 blockade and radiotherapy in vivo.